About the Ependymoma Session
Ependymoma, a rare type of brain or spinal cord cancer, presents complex challenges in both treatment and prognosis. Cancer research endeavors are actively exploring novel avenues to comprehend its underlying biology and enhance therapeutic approaches. Investigations into the intricate molecular pathways driving ependymoma formation are underway, aiming to identify potential targets for tailored interventions. Moreover, advancements in imaging technologies are facilitating early detection and precise surgical interventions, thereby optimizing patient outcomes. Promising directions in research encompass immunotherapy, targeted therapies, and innovative combination treatments, offering a beacon of hope for improved efficacy and reduced invasiveness. The collaborative synergy among clinicians, researchers, and pharmaceutical entities propels forward momentum in ependymoma research, with the ultimate goal of elevating survival rates and enhancing the quality of life for affected individuals.
Topics Covered in Ependymoma
Posterior Fossa Tumors
Supratentorial Tumors
Spinal Cord Tumors
Molecular Subgroups
Gross Total Resection
Focal Radiotherapy
Related Scientific Sessions at CIOC 2027
Why Attend the Ependymoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Ependymoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Ependymoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Ependymoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Ependymoma Conference 2027 — FAQs
What is the Ependymoma track at CIOC 2027?
The Ependymoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Ependymoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Ependymoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Ependymoma are all welcome — whether presenting or attending.
Can I present my research in the Ependymoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Ependymoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Ependymoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.